Katholisches Klinikum Bochum gGmbH

Kasalxona rejasiga kiritilgan kasalxona · Hattingen, Ruhr · notijorat

Revmatologiya va klinik immunologiyaEndokrinologiya va diabetologiyaOrtopediya: yelka, chanoq va tizzaOrtopediya va konservativ davolashTabiiy davolash va fitoterapiya

Taqqoslash

Toʻshaklar soni: 146. Germaniya kasalxonalarining 48 % undan kichikroq. Mamlakat medianasi: 151.

eng kichikmedian 151eng katta

Bu taqqoslashlar hech bir kasalxona saytida yoʻq. Ular faqat shu sababli mavjudki, bir xil maʼlumotlar bir xil shaklda barcha 2 758 muassasa uchun ochiq.

Maʼlumotlar

TaʼsischiKatholisches Klinikum Bochum gGmbH
Taʼsischi turinotijorat
Muassasa turiKasalxona rejasiga kiritilgan kasalxona
Toʻshaklar146
Boʻlimlar4
Telefon+49 234 509-0
E-pochtainfo@klinikum-bochum.de

Boʻlimlar

§ 301 SGB V boʻyicha nomlar va toʻshaklar soni, rasmiy reyestrdan aynan olingan.

Boʻlimlar	Toʻshaklar
Ortopediya: yelka, chanoq va tizzaOrthopädie	60
Tabiiy davolash va fitoterapiyaInnere Medizin/Schwerpunkt Naturheilkunde	35
Revmatologiya va klinik immunologiyaInnere Medizin/Schwerpunkt Rheumatologie	31
Endokrinologiya va diabetologiyaInnere Medizin/Schwerpunkt Diabetes	20
Jami	146

Nashrlar

Muallif mansubligida ushbu muassasani ko'rsatgan ilmiy nashrlar: 377 · dan beri 2010

Muallif mansubligiga ko'ra ixtisoslashgan nashrlar – davolash natijasi yoki muassasa sifati haqida da'vo emas. MedVici Health hozircha saraton bilan bog'liq nashrlarni ko'rsatmaydi.

Eng yangilari:

Disrupted brain network topology and structure-function coupling in non-specific low back painImaging neuroscience (Cambridge, Mass.) · 2026
Establishing cardiovascular safety of the small-molecule GLP-1 receptor agonist orforglipron in type 2 diabetesLancet (London, England) · 2026
Outcomes in patients with diabetes, atherosclerotic cardiovascular disease, and heart failure treated with tirzepatide or dulaglutide: SURPASS-CVOT analysisEuropean journal of preventive cardiology · 2026
Disease Activity During Pregnancy and Postpartum in Women With Multiple Sclerosis Treated With Ocrelizumab or Rituximab Before PregnancyNeurology(R) neuroimmunology & neuroinflammation · 2026
Estimating the True MACE Benefits From Tirzepatide in SURPASS-CVOT Using an Imputed Placebo Analysis of REWINDDiabetes care · 2026 · Tadqiqot
Return to sports after lumbar disc herniation surgery: a survey of German surgeons and postoperative patient experiencesEuropean spine journal : official publication of the European Spine Society, the European Spinal Deformity Society, and the European Section of the Cervical Spine Research Society · 2026
Cladribin-Tabletten bei Multipler Sklerose: therapiefreie Remission als Basis für sichere FamilienplanungDGNeurologie · 2026
Pregnancy and Infant Outcomes From an Ongoing Worldwide Enhanced Pharmacovigilance Program of Cladribine Tablets: 7-year Results of MAPLE-MSMultiple Sclerosis and Related Disorders · 2026
Humoral responses and 1-year follow up of infants potentially exposed to ocrelizumab during pregnancy and breastfeeding: final analyses of the prospective, multicentre, open-label, Phase IV studies MINORE and SOPRANINOMultiple Sclerosis and Related Disorders · 2026
Challenges in the management of age-related hearing loss in Germany: HearForFutureLaryngo- rhino- otologie · 2026

MedVici Media'dagi barcha yozuvlar

Moslashtirish nashrning muallif mansubligi bo'yicha amalga oshiriladi. Ma'lumotlar: PubMed (U.S. National Library of Medicine) va OpenAlex. Ro'yxat muassasani ham, uning davolash usullarini ham baholamaydi.